Literature DB >> 33466733

MBNL2 Regulates DNA Damage Response via Stabilizing p21.

Jin Cai1,2, Ningchao Wang1,2, Guanglan Lin1,2, Haowei Zhang1,3, Weidong Xie1,3, Yaou Zhang1,3, Naihan Xu1,3.   

Abstract

RNA-binding proteins are frequently dysregulated in human cancer and able to modulate tumor cell proliferation as well as tumor metastasis through post-transcriptional regulation on target genes. Abnormal DNA damage response and repair mechanism are closely related to genome instability and cell transformation. Here, we explore the function of the RNA-binding protein muscleblind-like splicing regulator 2 (MBNL2) on tumor cell proliferation and DNA damage response. Transcriptome and gene expression analysis show that the PI3K/AKT pathway is enriched in MBNL2-depleted cells, and the expression of cyclin-dependent kinase inhibitor 1A (p21CDKN1A) is significantly affected after MBNL2 depletion. MBNL2 modulates the mRNA and protein levels of p21, which is independent of its canonical transcription factor p53. Moreover, depletion of MBNL2 increases the phosphorylation levels of checkpoint kinase 1 (Chk1) serine 345 (S345) and DNA damage response, and the effect of MBNL2 on DNA damage response is p21-dependent. MBNL2 would further alter tumor cell fate after DNA damage, MBNL2 knockdown inhibiting DNA damage repair and DNA damage-induced senescence, but promoting DNA damage-induced apoptosis.

Entities:  

Keywords:  Chk1; DNA damage response; MBNL2; RNA-binding protein; cancer; p21

Mesh:

Substances:

Year:  2021        PMID: 33466733      PMCID: PMC7829980          DOI: 10.3390/ijms22020783

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  43 in total

Review 1.  Cellular senescence: when bad things happen to good cells.

Authors:  Judith Campisi; Fabrizio d'Adda di Fagagna
Journal:  Nat Rev Mol Cell Biol       Date:  2007-09       Impact factor: 94.444

2.  Lack of PTEN sequesters CHK1 and initiates genetic instability.

Authors:  Janusz Puc; Megan Keniry; Hong Shen Li; Tej K Pandita; Atish D Choudhury; Lorenzo Memeo; Mahesh Mansukhani; Vundavalli V V S Murty; Zbigniew Gaciong; Sarah E M Meek; Helen Piwnica-Worms; Hanina Hibshoosh; Ramon Parsons
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

3.  Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.

Authors:  G Lossaint; E Besnard; D Fisher; J Piette; V Dulić
Journal:  Oncogene       Date:  2011-05-02       Impact factor: 9.867

4.  Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy.

Authors:  Chien-Hsiang Hsu; Steven J Altschuler; Lani F Wu
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

5.  The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein.

Authors:  Keith M Giles; John M Daly; Dianne J Beveridge; Andrew M Thomson; Dominic C Voon; Henry M Furneaux; Jalal A Jazayeri; Peter J Leedman
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

6.  Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation.

Authors:  Masato Yano; Hirotaka J Okano; Hideyuki Okano
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

Review 7.  The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.

Authors:  Maya Pascual; Marta Vicente; Lidon Monferrer; Ruben Artero
Journal:  Differentiation       Date:  2006-03       Impact factor: 3.880

8.  AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51.

Authors:  Isabelle Plo; Corentin Laulier; Laurent Gauthier; Fabienne Lebrun; Fabien Calvo; Bernard S Lopez
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

9.  The cyclin-dependent kinase inhibitor p21 is regulated by RNA-binding protein PCBP4 via mRNA stability.

Authors:  Ariane Scoumanne; Seong Jun Cho; Jin Zhang; Xinbin Chen
Journal:  Nucleic Acids Res       Date:  2010-09-03       Impact factor: 16.971

10.  Muscleblind‑like 1 destabilizes Snail mRNA and suppresses the metastasis of colorectal cancer cells via the Snail/E‑cadherin axis.

Authors:  Liang Tang; Peng Zhao; Dalu Kong
Journal:  Int J Oncol       Date:  2019-01-18       Impact factor: 5.650

View more
  2 in total

Review 1.  CELF Family Proteins in Cancer: Highlights on the RNA-Binding Protein/Noncoding RNA Regulatory Axis.

Authors:  Maryam Nasiri-Aghdam; Texali C Garcia-Garduño; Luis Felipe Jave-Suárez
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

2.  Novel DNA Damage-Related Subtypes Characterization Identifies Uterine Corpus Endometrial Carcinoma (UCEC) Based on Machine Learning.

Authors:  Qi Yu; Xinqi Ge; Zheng Wang; Shu Ding; Yunfeng Jin; Liping Chen
Journal:  J Oncol       Date:  2022-08-28       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.